The DOI matches its Crossref record.
Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone.
Abstract
Twenty-three patients with sustained, recurrent, symptomatic ventricular tachycardia were treated with oral amiodarone. Initial doses were 600-2000 mg/day and maintenance doses were 200-1200 mg/day. Amiodarone was highly effective in 20 patients (87%), seven of whom had a follow-up of 30 months or longer, including two who were followed for 5 years. Three patients died within the first 45 days, three died suddenly after a follow-up of 33.5 months, and four had a nonarrhythmic death after a follow-up of 25 months. Fifteen patients (65%) had no recurrence during a follow-up of 21.5 months, while five (22%) had isolated recurrences during a follow-up of 32.2 months. The average maintenance dose was 713 mg/day in the 15 patients who did not have recurrences and 375 mg/day in the five patients who had recurrences (p less than 0.001). Both short- and long-term tolerance were excellent and there was not a single case in which treatment had to be discontinued. The main disadvantage of amiodarone was that it took an average of 9.5 days to reach anti-arrhythmic efficacy. The main advantages were prolonged duration of action (recurrences occurred only 15-60 days after the drug was discontinued or the dose lowered, virtual absence of contraindications, doses as high as 2000 mg/day were safe and patient compliance was excellent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Randomised trial of low-dose amiodarone in severe congestive heart failure
Doval, H., Nul, D., Grancelli, H., Perrone, S., Bortman, G., & Curiel, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91895-3 · Cited by 920
Clinical Pharmacokinetics of Amiodarone
Latini, R., Tognoni, G., & Kates, R. E. (1984) · Clinical Pharmacokinetics · doi:10.2165/00003088-198409020-00002 · Cited by 333
MARCHLINSKI, F. E., GANSLER, T. S., WAXMAN, H. L., & JOSEPHSON, M. E. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-6-839 · Cited by 311
Evidence-Based Analysis of Amiodarone Efficacy and Safety
Connolly, S. J. (1999) · Circulation · doi:10.1161/01.cir.100.19.2025 · Cited by 307
Metadata
- Authors
- Kaski, J. C., Girotti, L. A., Messuti, H., Rutitzky, B., & Rosenbaum, M. B.
- Venue
- Circulation
- Published
- 1981-08
- Volume
- 64
- Issue
- 2
- Pages
- 273-279
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1981023628
- Cited by
- 190
- References
- 0
- FWCI
- 29.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.